New Delhi: Two global pharmaceutical firms - Hilleman Laboratories and Gotovax AB - Tuesday joined hands to develop affordable oral cholera vaccine.

"Our partnership with Gotovax AB is carefully aligned to Hilleman Laboratories' core philosophy of addressing unmet health needs of the underprivileged by developing accessible and innovative vaccines which are affordable," Hilleman Laboratories' chief executive officer Davinder Gill said.